- Home
- ATPC vs BIAF Comparison
ATPC vs BIAF Comparison
Compare ATPC & BIAF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ATPC | BIAF |
|---|---|---|
| Founded | 2016 | 2014 |
| Country | Malaysia | United States |
| Employees | N/A | 57 |
| Industry | Medical/Nursing Services | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.9M | 4.6M |
| IPO Year | 2017 | N/A |
Fundamental Metrics
Financial Performance| Metric | ATPC | BIAF |
|---|---|---|
| Price | $2.25 | $2.79 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 1 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 2.5M | ★ 14.8M |
| Earning Date | 04-06-2026 | 03-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,322,747.00 | N/A |
| Revenue This Year | N/A | $20.95 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.05 | $0.16 |
| 52 Week High | $6.30 | $13.50 |
Technical Indicators
Market Signals| Indicator | ATPC | BIAF |
|---|---|---|
| Relative Strength Index (RSI) | 48.05 | 72.83 |
| Support Level | $1.28 | $1.13 |
| Resistance Level | $2.55 | $3.58 |
| Average True Range (ATR) | 0.60 | 0.37 |
| MACD | -0.15 | 0.20 |
| Stochastic Oscillator | 11.34 | 68.45 |
Price Performance
Historical ComparisonAbout ATPC Agape ATP Corporation
Agape ATP Corp through its subsidiaries is engaged in providing health and wellness products and health solution advisory services. The principal activities of the company is to supply high-quality health and wellness products, including supplements to assist in cell metabolism, detoxification, blood circulation, anti-aging and products designed to improve the overall health system of the human body and various wellness programs. Its segments include: Skin care, health and wellness segment includes the provision of health and wellness products and health solution advisory services; and Green energy segment includes providing renewable energy products, technical solutions, installations and maintenance services. It derives maximum revenue from Skin care, health and wellness segment.
About BIAF bioAffinity Technologies Inc.
bioAffinity Technologies Inc addresses the need for noninvasive diagnosis of early-stage cancer and diseases of the lung and targeted cancer treatment. It develops proprietary noninvasive diagnostic tests and cancer therapeutics using technology that preferentially targets cancer cells and cell populations indicative of a diseased state. The company's product, CyPath Lung, is a noninvasive test for the detection of early-stage lung cancer.